Cargando…

Epstein-Barr virus-positive multiple myeloma following an ABO incompatible second renal transplantation

ABO incompatible kidney transplant recipients receive higher dose of immunosuppression. Previous data indicate that the incidence of malignancy is not higher in these patients. Compared to the general population, renal transplant recipients are at 4.4-fold higher risk of developing myeloma. We descr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirushnan, B., Subbarao, B., Prabhu, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964689/
https://www.ncbi.nlm.nih.gov/pubmed/27512301
http://dx.doi.org/10.4103/0971-4065.168143
_version_ 1782445156707860480
author Kirushnan, B.
Subbarao, B.
Prabhu, P.
author_facet Kirushnan, B.
Subbarao, B.
Prabhu, P.
author_sort Kirushnan, B.
collection PubMed
description ABO incompatible kidney transplant recipients receive higher dose of immunosuppression. Previous data indicate that the incidence of malignancy is not higher in these patients. Compared to the general population, renal transplant recipients are at 4.4-fold higher risk of developing myeloma. We describe a case of posttransplant multiple myeloma in an ABO incompatible renal transplant recipient of a second graft.
format Online
Article
Text
id pubmed-4964689
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-49646892016-08-10 Epstein-Barr virus-positive multiple myeloma following an ABO incompatible second renal transplantation Kirushnan, B. Subbarao, B. Prabhu, P. Indian J Nephrol Case Report ABO incompatible kidney transplant recipients receive higher dose of immunosuppression. Previous data indicate that the incidence of malignancy is not higher in these patients. Compared to the general population, renal transplant recipients are at 4.4-fold higher risk of developing myeloma. We describe a case of posttransplant multiple myeloma in an ABO incompatible renal transplant recipient of a second graft. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4964689/ /pubmed/27512301 http://dx.doi.org/10.4103/0971-4065.168143 Text en Copyright: © 2016 Indian Journal of Nephrology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Case Report
Kirushnan, B.
Subbarao, B.
Prabhu, P.
Epstein-Barr virus-positive multiple myeloma following an ABO incompatible second renal transplantation
title Epstein-Barr virus-positive multiple myeloma following an ABO incompatible second renal transplantation
title_full Epstein-Barr virus-positive multiple myeloma following an ABO incompatible second renal transplantation
title_fullStr Epstein-Barr virus-positive multiple myeloma following an ABO incompatible second renal transplantation
title_full_unstemmed Epstein-Barr virus-positive multiple myeloma following an ABO incompatible second renal transplantation
title_short Epstein-Barr virus-positive multiple myeloma following an ABO incompatible second renal transplantation
title_sort epstein-barr virus-positive multiple myeloma following an abo incompatible second renal transplantation
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964689/
https://www.ncbi.nlm.nih.gov/pubmed/27512301
http://dx.doi.org/10.4103/0971-4065.168143
work_keys_str_mv AT kirushnanb epsteinbarrviruspositivemultiplemyelomafollowinganaboincompatiblesecondrenaltransplantation
AT subbaraob epsteinbarrviruspositivemultiplemyelomafollowinganaboincompatiblesecondrenaltransplantation
AT prabhup epsteinbarrviruspositivemultiplemyelomafollowinganaboincompatiblesecondrenaltransplantation